JPWO2019169004A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019169004A5
JPWO2019169004A5 JP2020545159A JP2020545159A JPWO2019169004A5 JP WO2019169004 A5 JPWO2019169004 A5 JP WO2019169004A5 JP 2020545159 A JP2020545159 A JP 2020545159A JP 2020545159 A JP2020545159 A JP 2020545159A JP WO2019169004 A5 JPWO2019169004 A5 JP WO2019169004A5
Authority
JP
Japan
Prior art keywords
seq
acid sequence
protein
capsid
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020545159A
Other languages
English (en)
Japanese (ja)
Other versions
JP7498665B2 (ja
JP2021515548A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/019861 external-priority patent/WO2019169004A1/en
Publication of JP2021515548A publication Critical patent/JP2021515548A/ja
Publication of JPWO2019169004A5 publication Critical patent/JPWO2019169004A5/ja
Application granted granted Critical
Publication of JP7498665B2 publication Critical patent/JP7498665B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020545159A 2018-02-27 2019-02-27 新規アデノ随伴ウイルス(aav)ベクター、低減されたカプシド脱アミド化を有するaavベクター、およびその使用 Active JP7498665B2 (ja)

Applications Claiming Priority (29)

Application Number Priority Date Filing Date Title
US201862635968P 2018-02-27 2018-02-27
US201862635964P 2018-02-27 2018-02-27
US62/635,964 2018-02-27
US62/635,968 2018-02-27
US201862663797P 2018-04-27 2018-04-27
US201862663788P 2018-04-27 2018-04-27
US62/663,788 2018-04-27
US62/663,797 2018-04-27
US201862667587P 2018-05-06 2018-05-06
US62/667,585 2018-05-06
US62/667,587 2018-05-06
US201862667888P 2018-05-07 2018-05-07
US201862667881P 2018-05-07 2018-05-07
US62/667,881 2018-05-07
US62/667,888 2018-05-07
US201862677471P 2018-05-29 2018-05-29
US201862667585P 2018-05-29 2018-05-29
US201862677474P 2018-05-29 2018-05-29
US62/677,471 2018-05-29
US62/677,474 2018-05-29
US201862703673P 2018-07-26 2018-07-26
US201862703670P 2018-07-26 2018-07-26
US62/703,673 2018-07-26
US62/703,670 2018-07-26
US201862722382P 2018-08-24 2018-08-24
US201862722388P 2018-08-24 2018-08-24
US62/722,382 2018-08-24
US62/722,388 2018-08-24
PCT/US2019/019861 WO2019169004A1 (en) 2018-02-27 2019-02-27 Novel adeno-associated virus (aav) vectors, aav vectors having reduced capsid deamidation and uses therefor

Publications (3)

Publication Number Publication Date
JP2021515548A JP2021515548A (ja) 2021-06-24
JPWO2019169004A5 true JPWO2019169004A5 (hr) 2022-02-18
JP7498665B2 JP7498665B2 (ja) 2024-06-12

Family

ID=67809202

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020545159A Active JP7498665B2 (ja) 2018-02-27 2019-02-27 新規アデノ随伴ウイルス(aav)ベクター、低減されたカプシド脱アミド化を有するaavベクター、およびその使用

Country Status (14)

Country Link
US (1) US20210123073A1 (hr)
EP (1) EP3768695A4 (hr)
JP (1) JP7498665B2 (hr)
KR (1) KR20210006327A (hr)
CN (1) CN112236443A (hr)
AU (1) AU2019228504A1 (hr)
BR (1) BR112020017278A2 (hr)
CA (1) CA3091795A1 (hr)
CL (1) CL2020002201A1 (hr)
IL (1) IL276860A (hr)
MA (1) MA52087A (hr)
MX (1) MX2020008932A (hr)
SG (1) SG11202007942YA (hr)
WO (1) WO2019169004A1 (hr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10202107733QA (en) 2015-09-28 2021-09-29 Univ North Carolina Chapel Hill Methods and compositions for antibody-evading virus vectors
WO2019195449A1 (en) 2018-04-03 2019-10-10 Stridebio, Inc. Antibody-evading virus vectors
EP3884057A4 (en) * 2018-12-21 2022-09-07 The University of North Carolina at Chapel Hill OPTIMIZED GALC GENES AND EXPRESSION CASSETTE AND THEIR USE
MX2021011468A (es) 2019-03-21 2021-12-15 Vectores de virus adenoasociados recombinantes.
WO2021076925A1 (en) 2019-10-17 2021-04-22 Stridebio, Inc. Adeno-associated viral vectors for treatment of niemann-pick disease type c
TW202130653A (zh) * 2019-10-21 2021-08-16 賓州大學委員會 具改進生產產率及肝臟趨性之aav3b變異體
MX2022008003A (es) * 2020-01-03 2022-10-07 Sarepta Therapeutics Inc Métodos para analizar proteínas de la cápside de aav.
WO2021183433A1 (en) * 2020-03-09 2021-09-16 University Of Massachusetts Gene replacement therapy for foxg1 syndrome
WO2021257668A1 (en) 2020-06-17 2021-12-23 The Trustees Of The University Of Pennsylvania Compositions and methods for treatment of gene therapy patients
IL299762A (en) 2020-07-13 2023-03-01 Univ Pennsylvania Useful preparations for the treatment of Charcot-Marietot disease
CA3195553A1 (en) * 2020-10-18 2022-04-21 Qiang Wang Improved adeno-associated virus (aav) vector and uses therefor
CA3209779A1 (en) 2021-02-01 2022-08-04 Regenxbio Inc. Gene therapy for neuronal ceroid lipofuscinoses
JP2024515612A (ja) 2021-04-12 2024-04-10 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア 球脊髄性筋萎縮症(sbma)の治療に有用な組成物
WO2023081807A1 (en) * 2021-11-04 2023-05-11 The Trustees of the University of Pennsylvania Penn Center for Innovation Compositions and methods for reducing pcsk9 levels in a subject
WO2023133584A1 (en) 2022-01-10 2023-07-13 The Trustees Of The University Of Pennsylvania Compositions useful in treatment of metachromatic leukodystrophy
WO2023133574A1 (en) 2022-01-10 2023-07-13 The Trustees Of The University Of Pennsylvania Compositions and methods useful for treatment of c9orf72-mediated disorders
WO2023196892A1 (en) 2022-04-06 2023-10-12 The Trustees Of The University Of Pennsylvania Passive immunization with anti- aav neutralizing antibodies to prevent off-target transduction of intrathecally delivered aav vectors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070172460A1 (en) * 2003-03-19 2007-07-26 Jurgen Kleinschmidt Random peptide library displayed on aav vectors
DK3211085T3 (da) * 2003-09-30 2021-06-21 Univ Pennsylvania Klader af adeno-associeret virus (aav), sekvenser, vektorer indeholdende disse og anvendelser deraf
DK2359867T3 (en) 2005-04-07 2015-01-05 Univ Pennsylvania A method for increasing an AAV vector function
WO2016049230A1 (en) * 2014-09-24 2016-03-31 City Of Hope Adeno-associated virus vector variants for high efficiency genome editing and methods thereof
EP3224362A4 (en) * 2014-11-26 2018-06-06 The Regents of The University of California Therapeutic compositions comprising transcription factors and methods of making and using the same
IL298604A (en) * 2016-04-15 2023-01-01 Univ Pennsylvania Novel aav8 mutant capsids and preparations containing them
MX2019000962A (es) * 2016-07-26 2019-08-01 Biomarin Pharm Inc Novedosas proteinas de la capside del virus adenoasociado.
TN2019000047A1 (en) * 2016-08-15 2020-07-15 Genzyme Corp Methods for detecting aav
HRP20240257T1 (hr) * 2017-02-28 2024-05-24 The Trustees Of The University Of Pennsylvania Adeno-povezani virusni (aav) clade f vektor i njegova uporaba
JOP20190200A1 (ar) * 2017-02-28 2019-08-27 Univ Pennsylvania تركيبات نافعة في معالجة ضمور العضل النخاعي

Similar Documents

Publication Publication Date Title
JP2020510429A5 (hr)
JPWO2019169004A5 (hr)
CN109563496B (zh) 用于重组蛋白和/或病毒载体生产的细胞系
JP5268890B2 (ja) Aavの規模適応性の製造方法
FI3589730T3 (fi) Kladin f adenoassosioitunut virus (aav) -vektori ja sen käyttötapoja
US6593123B1 (en) Large-scale recombinant adeno-associated virus (rAAV) production and purification
US7220577B2 (en) Modified AAV
JP2018108113A5 (hr)
JPWO2019168961A5 (hr)
IL259595B2 (en) Gradual methods for the production of a recombinant adenovirus (AAV) vector in a serum-free suspension cell culture system suitable for clinical use
CN110997912A (zh) 用于改进的细胞转染和/或rAAV载体生产的增强剂
US11905524B2 (en) AAV chimeras
AU2003272672B2 (en) High titer recombinant AAV production
US20220186255A1 (en) Methods for the manufacture of recombinant viral vectors
JPWO2020223232A5 (hr)
JP2023518919A (ja) Aavを産生する方法
JPWO2020223236A5 (hr)
JPWO2020223231A5 (hr)
JP7481755B2 (ja) 組換えパルボウイルスベクターならびにその作製および使用方法
JP2024514956A (ja) 組織標的化された改変aavカプシドおよびその使用方法
AR123838A1 (es) Vector mejorado de virus adenoasociado (aav) y usos de este
JP2023529855A (ja) Smn1タンパク質をコードするコドン最適化した核酸およびその使用
US20240084268A1 (en) Method for purifying recombinant viral particles
CN116063404A (zh) 可提高AAV包装能力的衣壳蛋白MutD及其应用
RU2820088C1 (ru) Выделенный модифицированный белок VPI капсида аденоассоциированного вируса 5 серотипа (AAV5), капсид и вектор на его основе